Osman Ronald E's Form 4 filing
Inhibitor Therapeutics, Inc. (INTI) · filed Aug 4, 2026
- Accession no.
- 0001493152-26-035962
- Filed
- Aug 4, 2026, 1:33 PM ET
- Trade date
- May 4, 2026
- Filing delay
- 92 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. It was filed 92 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Osman Ronald ECIK 0001380466 | Director, 10% Owner |
| Ronald E. Osman Irrevocable Trust III under Agreement dated May 13, 2012CIK 0001972372 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | AGrant or awardAcquired | +50,000 | $0.00 | $0 | 23,614,985 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.